NO20003042L - FremgangsmÕte for profylaktisk behandling av mastitt - Google Patents

FremgangsmÕte for profylaktisk behandling av mastitt

Info

Publication number
NO20003042L
NO20003042L NO20003042A NO20003042A NO20003042L NO 20003042 L NO20003042 L NO 20003042L NO 20003042 A NO20003042 A NO 20003042A NO 20003042 A NO20003042 A NO 20003042A NO 20003042 L NO20003042 L NO 20003042L
Authority
NO
Norway
Prior art keywords
mastitis
procedure
prophylactic treatment
prophylactic
treatment
Prior art date
Application number
NO20003042A
Other languages
English (en)
Other versions
NO20003042D0 (no
NO327301B1 (no
Inventor
Ke Lignell
Johan Inborr
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Publication of NO20003042D0 publication Critical patent/NO20003042D0/no
Publication of NO20003042L publication Critical patent/NO20003042L/no
Publication of NO327301B1 publication Critical patent/NO327301B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20003042A 1997-12-16 2000-06-14 Anvendelse av astaxanthin for fremstilling av et medikament til behandling av mastitt NO327301B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
PCT/SE1998/002279 WO1999030701A1 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis

Publications (3)

Publication Number Publication Date
NO20003042D0 NO20003042D0 (no) 2000-06-14
NO20003042L true NO20003042L (no) 2000-06-14
NO327301B1 NO327301B1 (no) 2009-06-02

Family

ID=20409414

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003042A NO327301B1 (no) 1997-12-16 2000-06-14 Anvendelse av astaxanthin for fremstilling av et medikament til behandling av mastitt

Country Status (12)

Country Link
US (1) US6335015B1 (no)
EP (1) EP1049460B1 (no)
JP (1) JP2002508318A (no)
AR (1) AR017877A1 (no)
AT (1) ATE239457T1 (no)
AU (1) AU743198B2 (no)
CA (1) CA2314170C (no)
DE (1) DE69814467D1 (no)
NO (1) NO327301B1 (no)
NZ (1) NZ504801A (no)
SE (1) SE511237C2 (no)
WO (1) WO1999030701A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7345091B2 (en) 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
EP1532108B1 (en) 2002-07-29 2016-06-29 Cardax Pharma, Inc. Astaxanthin esters for the inhibition and amelioration of disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
CA2564066A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2006034570A1 (en) 2004-09-28 2006-04-06 Chemaphor Inc. Compositions and methods for promoting weight gain and feed conversion
WO2006039685A2 (en) * 2004-10-01 2006-04-13 Hawaii Biotech, Inc. Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid derivatives
AU2008316225B2 (en) 2007-10-26 2014-06-19 Avivagen Inc. Compositions and methods for enhancing immune response
WO2010124392A1 (en) * 2009-04-30 2010-11-04 Chemaphor Inc. Methods, compositions, and kits for the treatment of inflammatory conditions
WO2010124391A1 (en) 2009-04-30 2010-11-04 Chemaphor Inc. Methods and compositions for improving the health of animals
CA3168140A1 (en) * 2020-02-18 2021-08-26 Avivagen Inc. Supplemented animal feeds for mammals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2619491B2 (ja) 1988-08-11 1997-06-11 サントリー株式会社 アスタキサンチン含有組成物
AU4715796A (en) 1995-02-03 1996-08-21 Basf Aktiengesellschaft Use of carotinoids for preparing medicaments for treating dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE506191C2 (sv) * 1996-03-27 1997-11-17 Astacarotene Ab Medel och sätt för att öka produktionen av/hos däggdjur

Also Published As

Publication number Publication date
NO20003042D0 (no) 2000-06-14
SE9704693L (sv) 1999-06-17
NO327301B1 (no) 2009-06-02
DE69814467D1 (de) 2003-06-12
NZ504801A (en) 2002-05-31
ATE239457T1 (de) 2003-05-15
AR017877A1 (es) 2001-10-24
CA2314170A1 (en) 1999-06-24
WO1999030701A1 (en) 1999-06-24
JP2002508318A (ja) 2002-03-19
US6335015B1 (en) 2002-01-01
SE511237C2 (sv) 1999-08-30
SE9704693D0 (sv) 1997-12-16
EP1049460A1 (en) 2000-11-08
AU1897299A (en) 1999-07-05
AU743198B2 (en) 2002-01-24
EP1049460B1 (en) 2003-05-07
CA2314170C (en) 2008-01-29

Similar Documents

Publication Publication Date Title
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO20003042D0 (no) FremgangsmÕte for profylaktisk behandling av mastitt
NO983766D0 (no) FremgangsmÕte til fremstilling av N-acetyl-D-glukosamin
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
FI962499A (fi) Herbisidien tehon parantaminen
NO20010456D0 (no) Triazolopyridiner for behandling av trombose-problemer
NO983068D0 (no) FremgangsmÕte for fremstilling av bis-syklopentadienyl-dien komplekser
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO984432L (no) FremgangsmÕte for behandling av migrenesmerte
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
EE200000055A (et) Protsess tsüklopropüülatsetüleeni valmistamiseks
NO983784L (no) Fremgangsmåter for fremstilling av bifenyl-isoksasolsulfonamider
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO984905D0 (no) FremgangsmÕte for fremstilling av b°rstevarer
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
NO991158D0 (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
NO307859B1 (no) FremgangsmÕte for beregning av varighet av oppkoblinger
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO985558D0 (no) Ny forbedret formulering for behandling av tromboembolisme

Legal Events

Date Code Title Description
MK1K Patent expired